Connect with us

Apyx doubles revenue in Q3

November 12, 2019 - Apyx Medical Corp. (Nasdaq: APYX), a Clearwater medical device firm, posted $7.6 million in revenue from continuing operations in the third quarter of 2019, up 106 percent over Q3 2018. The company’s net loss for the three months ended Sept. 30 was $4.3 million, or 13 cents a share. The company, formerly named Bovie Medical, revamped its operations after selling its legacy electrosurgical business in 2018.  Apyx expects total revenue in the range of $27.4 million to $27.9 million and a net loss in the range of $20.3 million to $19.8 million for the full year of fiscal 2019, a news release said. Apyx had the best performing stock among Tampa-St. Pete area public companies in 2018 and the stock price has risen about 12 percent since the first of the year.

More Zaps Frontpage

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us: spark@stpetecatalyst.com

Subscribe for Free

Share with friend

Please enter email address you want to share this article with